Blood Glucose at Altitude: What Happens at 30,000 Feet?
This event explores advanced diabetes management technologies, focusing on studies showing improved Time in Range and sensor accuracy in challenging conditions.
- The description claims that 12 months of Tandem Control-IQ use significantly increases Time in Range from 58.8% to 70.9%, reducing severe hypoglycaemic events and work absenteeism.
- The description claims that modern CGM sensors maintain clinical accuracy in hypobaric flight simulations.
AI Readiness
Good foundation, but some important product data is still missing.
72%